±è¹Ì±Ý ¸íÀÇ

°¢¸· ÀÌÁ¾ÀÌ½Ä ¿¬±¸ Ȱ¹ß

±è¹Ì±Ý ¸íÀÇ

  • ¼Ò ¼Ó
    ¼­¿ï´ëº´¿ø ¾È°ú
  • Áø·á°ú
    ¾È°ú
  • Àü¹®ºÐ¾ß
    ¹é³»Àå ¹× °¢¸·Áúȯ (¹é³»Àå, °¢¸·, °¢¸·À̽Ä, ¾È±¸°ÇÁ¶Áõ, ³ë¾È)
ÁÖ¿ä Áø·á ºÐ¾ß´Â ¹é³»Àå, °¢¸·À̽Ä, °Ç¼º¾È, ±¼Àý¼ö¼ú, Ư¼öÄÜÅÃÆ®·»ÁîŬ¸®´ÐÀÌ´Ù. ƯÈ÷ ¿øÃß°¢¸·°ú ³­Ä¡¼ºÀ±ºÎ°áÇÌÁúȯÀÚ¸¦ À§ÇÑ Àü¹® Ŭ¸®´ÐÀ» ¿î¿µÇϰí ÀÖ´Ù. ³­Ä¡¼ºÀ±ºÎ°áÇÌÁúȯÀ» Ä¡·áÇϱâ À§ÇÑ Àç»ýÀÇÇÐ ¿¬±¸¿Í °¢¸·±âÁõÀÇ ºÎÁ· Çö»óÀ» ÇØ°áÇϱâ À§ÇÑ ´ëüÀÇÇÐÀÎ ÀÌÁ¾À̽ÄÀ» ¿¬±¸Çϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

  • ¼­¿ï´ëÇб³ Àǰú´ëÇпø ÀÇÇйڻç
  • ¼­¿ï´ëÇб³ Àǰú´ëÇпø ÀÇÇм®»ç
  • ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ÀÇÇаú

ÁÖ¿ä°æ·Â

  • úÞ) ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°ú ±³¼ö
  • Scripps Research Institute Àå±â¿¬¼ö (2008 ~ 2009)
  • ¹Ì±¹ Johns Hopkins Wilmer Eye Institute ´Ü±â¿¬¼ö (2005)

¼ö»ó³»¿ª

  • ´ëÇѾȰúÇÐȸ ÅÂÁØ ÃÖ´ÙÇÇÀοë KJO³í¹® °ø·Î»ó (2015)

ÇÐȸȰµ¿

  • 2024. 1~ÇöÀçÇѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ ȸÀå
  • 2024. 1~ÇöÀçÇѱ¹¹é³»Àå±¼ÀýÇÐȸ ´ë¿ÜÇù·ÂÀÌ»ç
  • 2020. 3~ÇöÀç Çѱ¹°Ç¼º¾ÈÇÐȸ ÆíÁýÀÌ»ç

ÁýÇÊÀú¼­

ÃÑ 3°Ç
ÃֽŠÄÜÅÃÆ®·»Áî ÀÓ»óÇÐ
´ëÇ¥¼­Àû

ÃֽŠÄÜÅÃÆ®·»Áî ÀÓ»óÇÐ

  • ÀúÀÚ(±Û)Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ
  • ÃâÆÇ»ç±ºÀÚÃâÆÇ»ç
  • ¹ßÇàÀÏ2015³â
Á¦ ¸ñ ±¼Àý±³Á¤¼ö¼ú 3ÆÇ
ÃâÆÇ»ç ÃÖ½ÅÀÇÇлç
¹ßÇàÀÏ 2014
Á¦ ¸ñ °¢¸· 3ÆÇ
ÃâÆÇ»ç ÀÏÁ¶°¢
¹ßÇàÀÏ 2013

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Clinical Characteristics and Therapeutic Outcomes of Pediatric Blepharokeratoconjunctivitis
¹ßÇ¥³âµµ 2023-5
¹ßÇ¥Áö CORNEA
Á¦ ¸ñ Clinical Characteristics and Therapeutic Outcomes of Pediatric Blepharokeratoconjunctivitis
¹ßÇ¥³âµµ 2022-8
¹ßÇ¥Áö CORNEA
Á¦ ¸ñ Sutureless contact lens-type amniotic membrane for persistent epithelial defects after infectious keratitis
¹ßÇ¥³âµµ 2022-8
¹ßÇ¥Áö INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
Á¦ ¸ñ Clinical outcome of Descemet membrane endothelial keratoplasty (DMEK) with imported donor corneas in eyes of Asian patients; endothelium-in versus endothelium-out method
¹ßÇ¥³âµµ 2022-6
¹ßÇ¥Áö PLOS ONE
Á¦ ¸ñ Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome
¹ßÇ¥³âµµ 2022-4
¹ßÇ¥Áö BMC OPHTHALMOLOGY
Á¦ ¸ñ Proteomics Analysis of Aqueous Humor and Rejected Graft in Pig-to-Non-Human Primate Corneal Xenotransplantation
¹ßÇ¥³âµµ Frontiers in Immunology ¹ßÇ¥³â¿ù 2022-3
¹ßÇ¥Áö Frontiers in Immunology
Á¦ ¸ñ Clinical Outcomes in Maximum Tolerated Medical Therapy in Penetrating Keratoplasty for Bullous Keratopathy
¹ßÇ¥³âµµ 2022-3
¹ßÇ¥Áö Áö Frontiers in Medicine

¸íÀÇqna ¸íÀÇ QnA

°¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä
ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?
ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

¼­¿ï´ëº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1588-5700
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö
¼­¿ï´ëº´¿ø À̹ÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

¼­¿ï´ëº´¿øÀº º»¿øÀ» ºñ·ÔÇÑ ¾î¸°À̺´¿ø, ¾Ïº´¿ø, ÀÇ»ý¸í¿¬±¸¿øÀ¸·Î ±¸¼ºµÅ ÀÖ´Â Á¾ÇÕ ÀÇ·á±â°üÀ¸·Î 1786º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖ´Ù. 540¿© ¸íÀÇ ±³¼ö¿Í 5400¿© ¸íÀÇ Á÷¿øÀÌ ÇÏ·ç Æò±Õ 1700¿© ¸íÀÇ ÀÔ¿øÈ¯ÀÚ¿Í 8600¸íÀÌ ³Ñ´Â ¿Ü·¡È¯ÀÚ¸¦ µ¹º¸°í ÀÖ´Ù. ¼¼°èÀû ÷´Ü Áø·á ¿µ¿ªÀ» Áö¼ÓÀûÀ¸·Î È®º¸ÇÔÀ¸·Î½á ÃÖ»óÀÇ Áø·á ¼­ºñ½º¸¦ Á¦°øÇϰí, ¿ì¸®³ª¶ó ÀÇ·á ¼±ÁøÈ­¸¦ Ãß±¸ÇÏ´Â Á¤Ã¥ Çù·Â º´¿øÀÌ´Ù.

¼­¿ïƯº°½Ã Á¾·Î±¸ ´ëÇзΠ101

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä